The 691 Patent was previously the subject of invalidity allegations by Cobalt and Apotex in separate applications brought under the pre-amended Regulations. In each decision, the Federal Court found ...
(NASDAQ: LUMO) , a biopharmaceutical company advancing an oral therapeutic candidate for pediatric growth hormone deficiency (“PGHD”) through phase 2 clinical trials, has received a notice of ...
Sustainable Materials Research Center (SUSMAT-RC) is seeking a highly motivated and talented postdoctoral fellow to join our research team focused on the development of new sustainable formulations ...
Dublin, July 30, 2025 (GLOBE NEWSWIRE) -- The "Pharma Formulation Development Outsourcing Market Size and Growth Trends and Companies 2025-2033" report has been added to ResearchAndMarkets.com's ...
Formulation Development Outsourcing Market · GlobeNewswire Inc. Dublin, July 30, 2025 (GLOBE NEWSWIRE) -- The "Pharma Formulation Development Outsourcing Market Size and Growth Trends and Companies ...